# The Medicines (Products for Human Use) (Fees) Regulations 2012, Paragraph 5: Marketing authorizations


Unless paragraphs 6 to 10 apply, the fee payable under regulation 33(3) in connection with the holding of a marketing authorization relating to a medicinal product of a kind described in column 1 of the following table is the applicable fee specified in the corresponding entry in column 2 of that table.
Periodic fees for holding marketing authorization
Column 1
Type of Medicinal Product
Column 2
Fee payable
1. New Active Substance
£23,025
2. Parallel Import
£300
3. Others
(a)
Any product (not being a derivative of a new active substance) in respect of which a marketing authorization has been granted in consequence of a complex application submitted on or after 1st April 1989
£9,481
(b)
Prescription Only Medicine
(i)
Standard Fee
£2,371
(ii)
Reduced Rate Fee
£1,183
(iii)
Lower Fee
£300
(c)
Pharmacy
£300
(d)
General Sale List
£300
(e)
Herbal remedy
£75
(f)
Traditional herbal registrations
£75
(g)
National homoeopathic product
£75
(h)
Homoeopathic or anthroposophic product which is the subject of a licence of right
£75

---
Source: https://www.legislation.gov.uk/nisr/2012/134/schedule/4/paragraph/5 (the official version)
Page: https://openlegislation.uk/medicines-products-for-human-use-fees-regulations-2012/schedule-4/paragraph-5
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.